Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0036341 (
schizophrenia
)
60,220
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Weak support for linkage of
schizophrenia
to proximal Xq has previously been reported. In addition, an increased prevalence of thyroid disorder has been noted in families of individuals with
schizophrenia
. Recently, a gene mapped to Xq13 termed
HOPA
has been found to be associated with mental retardation, hypothyroidism, and depression and to function as a coactivator for the thyroid receptor. We therefore examined the
HOPA
gene in a group of 111 probands from a larger cohort of multiplex families with
schizophrenia
, several of whom (n = 53) also had a family history of hypothyroidism. Four males and two females were found with an alteration in exon 42 of the
HOPA
gene compared with 8/492 males and 18/471 females (942 X chromosomes) compared with consecutively screened newborns (chi(2) = 3.92, P < 0.05). However, when available family members of each of the probands with an exon 42 variation were subsequently screened, the mutation did not segregate with
schizophrenia
in three of five families, although all 6 probands with an exon 42 variation did have hypothyroidism in either themselves (n = 3) or their mothers (n = 3) (P < 0.008). These findings replicate prior findings demonstrating an association between
HOPA
polymorphisms and hypothyroidism. In addition, the increased frequency of
HOPA
variants in this population may also provide a genetic basis for the familial association of thyroid disease and
schizophrenia
.
...
PMID:Investigation of a candidate gene for schizophrenia on Xq13 previously associated with mental retardation and hypothyroidism. 1089 21
HOPA
is an Xq13 chromosome gene that codes for a RXR nuclear receptor co-activator. In a prior study of the genetic basis of
schizophrenia
, we showed that exonic polymorphisms in
HOPA
were associated with increased risk of
schizophrenia
and hypothyroidism in a large cohort of probands from New York. In an attempt to replicate these findings, we examined this relationship in a cohort of 173 schizophrenic probands (128 males and 45 females providing 218 alleles) from Iowa. Consistent with the prior findings, we found an increased rate of the HOPA12bP exonic polymorphism in schizophrenic probands compared with random newborn controls (9 of 218 alleles vs. 33 of 2,049 alleles, P < 0.02). Furthermore, retrospective review of the medical records showed that two of the nine probands possessing the HOPA12bp allele in whom thyroid function was assessed were hypothyroid compared with 6 of 164 probands possessing the normal HOPAwild allele(s) (P < 0.06). We conclude that the HOPA12bp polymorphism shows a nominally significant association with
schizophrenia
and a nominal trend for association with hypothyroidism in our study and that further studies are required to define the features of this syndrome and the molecular mechanisms of disease pathogenesis.
...
PMID:Population-based association analyses of the HOPA12bp polymorphism for schizophrenia and hypothyroidism. 1142 83
The
HOPA
gene in Xq13 is coding for a protein involved in a nuclear thyroid receptor complex. Previous studies suggested association of the dodecamer duplication in the OPA-repeat region in exon 43 (according to the genomic database sequence) with autism, mental retardation, and
schizophrenia
/hypothyroidism. We determined the frequency of this 12 bp duplication variant in a sample of 155 patients divided in different subtypes of autism, 278 parents of those patients, and 157 control individuals. The allele frequency of the duplication variant was not significantly different between autistic patients, their parents, and the control group. Therefore, it is unlikely that this 12 bp duplication variant of the
HOPA
gene has major relevance to the susceptibility to different subtypes of autism at least in this German patient sample. In addition, we identified a third variant with a 15 bp deletion in the OPA-repeat region, recently described by another group, in one autistic patient. This third allele was also present in the patient's nonautistic mother and sister, who are heterozygous for this variant, but could not be detected in any other individual genotyped in this study. Expression analysis revealed transcription of all three allelic variants in lymphoblastoid cell lines. Furthermore, we identified a new splice variant that utilizes an additional 9 bp of the 3' intron subsequent to exon 39. Both alternative transcripts are coexpressed in all fetal and adult tissues examined.
...
PMID:Association studies of the HOPA dodecamer duplication variant in different subtypes of autism. 1184 May 15
Variations in exon 42 of the
HOPA
(human opposite paired) gene have been associated with mental retardation, hypothyroidism and psychiatric disorders. We attempted to replicate the association with
schizophrenia
using 309 parent-offspring trios from Bulgaria and 367 unrelated cases and 368 blood donors from the UK. We also tested 125 bipolar trios from Bulgaria, 112 bipolar trios from the UK and a sample of 178 unrelated bipolar cases and 188 blood donors from the UK. The frequency of
HOPA
(12bp) in the 556 UK blood donors was 2.6% and it was not significantly different in the UK patients groups, where it ranged from 1.2 to 3.8%. Sixteen mothers transmitted the
HOPA
(12bp) allele to schizophrenic offspring, while 12 did not transmit, a non-significant difference. There was a trend for under-transmission of the rare allele to bipolar patients (T/NT = 4/10) and they had a lower rate of that allele than schizophrenic patients in the Bulgarian population (1% vs. 4.2%, P = 0.043). However the two diagnostic groups had similar allele frequencies in the UK populations: 2% versus 2.6%, P = 0.6. We conclude that the
HOPA
polymorphism is unlikely to be a major risk factor in the pathogenesis of these major psychiatric disorders although there could be a small effect in
schizophrenia
.
...
PMID:Association analysis of the HOPA12bp polymorphism in schizophrenia and manic depressive illness. 1262 58
HOPA
is a X-chromosome gene that encodes an essential nuclear receptor co-activator. Previously, we have demonstrated that an exonic polymorphism, termed
HOPA
(12bp), in the Opa (Opposite Paired) domain of this gene that is critical for neuronal growth and differentiation is associated with a low risk for
schizophrenia
. But curiously, we have also noted that all
HOPA
(12bp) probands have the same haplotype immediately surrounding the
HOPA
(12bp), and other investigators have found evidence of population stratification with the
HOPA
(12bp) allele. Since deleterious alleles are weeded from the population, and the
HOPA
(12bp) allele is not rare, these prior findings suggest the possibility that positive selection may be occurring with respect to the
HOPA
(12bp) allele and that unique phenotypic features may be associated with this allele. To test these hypotheses, we analyzed symptom data collected from schizophrenic probands and conducted haplotyping studies around the
HOPA
(12bp) polymorphism. Consistent with our hypotheses, genotyping studies of 43 unrelated
HOPA
(12bp) males and 137
HOPA
(wild) males demonstrated that the
HOPA
(12bp) allele is associated with a large conserved DNA haplotype that extends over several genes known to be critical for human survival. Furthermore, ANOVA analysis of symptom data demonstrated that
HOPA
(12bp) schizophrenic probands (n = 14) have significantly lower severity of negative symptoms (P < 0.002) and better attention (P < 0.002) than matched controls (n = 30). Taken together, these findings further refine the behavioral endophenotype associated with the
HOPA
(12bp) allele and suggest that the sequence surrounding
HOPA
may need to be considered to fully understand the molecular basis of the phenotype associated with the
HOPA
(12bp) allele.
...
PMID:Association of the HOPA12bp allele with a large X-chromosome haplotype and positive symptom schizophrenia. 1510 74
HOPA
(MED12) is an X-chromosome gene that codes for a critical member of the Mediator Complex, a group of proteins that regulates transcription via the nuclear receptor, Wnt and Receptor Tyrosine Kinase pathways. In prior association and meta-analyses, we have shown that the presence of an evolutionarily conserved, 12 bp (4 amino acid) insertional polymorphism in exon 43 of this gene is associated with increased risk for an endophenotype of
schizophrenia
. In this communication, we describe the results of our work with subjects and data from the National Institutes of Mental Health (NIMH) Genetics Initiative for
Schizophrenia
. We report that the presence of the
HOPA
(12bp) polymorphism is associated with increased risk for
schizophrenia
in subjects of European ancestry. In the light of this new study and the prior wealth of clinical and basic science data, we conclude that the
HOPA
(12bp) allele is a risk factor for
schizophrenia
in subjects of European ancestry and suggest that further studies to define the endophenotype and mechanisms of illness associated with this polymorphism are indicated.
...
PMID:The association of the HOPA(12bp) polymorphism with schizophrenia in the NIMH Genetics Initiative for Schizophrenia sample. 1729 34
Abnormalities of sex chromosomes are associated with various forms of neuropsychiatric disorders, such as
schizophrenia
. Turner syndrome occurs approximately threefold more frequently in female schizophrenics compared to the general female population. A single case is reported. We report on a case of a 41-year-old woman with Turner syndrome,
schizophrenia
, mental retardation, and hypothyroidism. A polymorphism of the
HOPA
gene within Xq13 termed
HOPA
(12bp) is associated with
schizophrenia
, mental retardation, and hypothyroidism. Interestingly, Xq13 is the X-chromosome region that contains the X-inactivation center and a gene escaping X-inactivation whose gene product may be involved in the X-inactivation process as well as in the pathogenesis of sex chromosome anomalies such as Turner syndrome. These genes that escape X-inactivation may produce their gene products in excess, influencing normal brain growth and differentiation. Our case gives a further hint for an involvement of the X-chromosome in the pathogenesis of
schizophrenia
.
...
PMID:Turner syndrome and schizophrenia: a further hint for the role of the X-chromosome in the pathogenesis of schizophrenic disorders. 2021 87
Turner syndrome is a sex-chromosome disorder; occurring in 1 in 2,500 female births. There are sporadic few case reports of concomitant Turner syndrome with
schizophrenia
worldwide. Most Turner females had a 45,X monosomy, whereas the majority of comorbidity between Turner syndrome and
schizophrenia
had a mosaic karyotype (45,X/46,XX). We present a case of a 21-year-old woman with Turner syndrome, mosaic karyotype (45,X/46,XX), showing mental retardation, hypothyroidism, and
schizophrenia
.
HOPA
gene within Xq13 is related to mental retardation, hypothyroidism, and
schizophrenia
. Our case may be a potential clue which supports the hypothesis for involvement of genes on X chromosome in development of
schizophrenia
. Further studies including comorbid cases reports are need in order to discern the cause of
schizophrenia
in patients having Turner syndrome.
...
PMID:Mosaic Turner syndrome associated with schizophrenia. 2492 63